Skip to main content
. 2012 Mar 5;3(5):811–817. doi: 10.3892/etm.2012.505

Figure 2.

Figure 2.

Correlation between CD44 expression and survival rates in patients with clear cell renal cell carcinoma. Five-year recurrence-free survival (P<0.001) (A); 5-year disease-specific survival (P<0.001) (B); and 5-year overall survival (P<0.001) (C).